Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Itamar Medical Gains Most in 4 Months on Chinese Approval

March 27 (Bloomberg) -- Itamar Medical Ltd. rose the most in almost four months after the maker of medical diagnostic equipment said two of its products were approved for distribution in China.

The shares gained 5.6 percent, the biggest increase since Dec. 7, to 2.08 shekels at the 4:30 p.m. close in Tel Aviv.

WatchPAT, a device for diagnosing sleep apnea, and the company’s non-invasive cardiovascular device EndoPAT can now be sold in the Asian country.

To contact the reporter on this story: Ronit Goodman in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.